With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

Inc. reported robust financial results for the fourth quarter of 2024, surpassing analysts' expectations with an earnings per share (EPS) of $2.31, slightly above the forecast of $2.30. The company's ...

Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...

Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it ...

About one in every six knee joint replacements is now performed with robotic assistance, according to orthopedic surgeons.

ZBH's Hips business is expected to have witnessed growth banking on its suite of navigation solutions in direct anterior stems and surgical impactors.

Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...

BTIG analysts maintained their Buy rating on Zimmer Biomet (NYSE:ZBH) with a price target of $126.00 after the company ...

A Vulture series in which artists judge the best and worst of their own careers. Right before Christmas, Zimmer appraised his career from the comforts of his opulent Santa Monica studio.

And Zimmer was on staff for Witten’s first four years with the Cowboys; it’s not like they’re total strangers. Of course, Zimmer could get invitations to interview with other clubs ...

Zimmer Biomet's ZBH strategic efforts to bolster ... CT scan-less robotic system in the current form factor of ROSA for total knee arthroplasty. The second pillar is focused on Persona revision.